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Abstract
The Protein Kinase G, EGL-4, is required within the C. elegans AWC sensory neurons to promote olfactory adaptation. After
prolonged stimulation of these neurons, EGL-4 translocates from the cytosol to the nuclei of the AWC. This nuclear
translocation event is both necessary and sufficient for adaptation of the AWC neuron to odor. A cGMP binding motif within
EGL-4 and the Ga protein ODR-3 are both required for this translocation event, while loss of the guanylyl cyclase ODR-1 was
shown to result in constitutively nuclear localization of EGL-4. However, the molecular changes that are integrated over time
to produce a stably adapted response in the AWC are unknown. Here we show that odor-induced fluctuations in cGMP
levels in the adult cilia may be responsible in part for sending EGL-4 into the AWC nucleus to produce long-term adaptation.
We found that reductions in cGMP that result from mutations in the genes encoding the cilia-localized guanylyl cyclases
ODR-1 and DAF-11 result in constitutively nuclear EGL-4 even in naive animals. Conversely, increases in cGMP levels that
result from mutations in cGMP phosphodiesterases block EGL-4 nuclear entry even after prolonged odor exposure.
Expression of a single phosphodiesterase in adult, naive animals was sufficient to modestly increase the number of animals
with nuclear EGL-4. Further, coincident acute treatment of animals with odor and the phosphodiesterase inhibitor 3-
isobutyl-1-methylxanthine (IBMX) decreased the number of animals with nuclear EGL-4. These data suggest that reducing
cGMP levels in AWC is necessary and even partially sufficient for nuclear translocation of EGL-4 and adaptation as a result of
prolonged odor exposure. Our genetic analysis and chemical treatment of C. elegans further indicate that cilia morphology,
as defined by fluorescent microscopic observation of the sensory endings, may allow for odor-induced fluctuations in cGMP
levels and this fluctuation may be responsible for sending EGL-4 into the AWC nucleus.
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Introduction
In order to effectively shape behavior, neural circuits must
integrate sensory information by collating input and placing this
input in a context of previous or concurrent sensory information.
This modulation of behavior by previous experience or against a
background of current input is termed behavioral plasticity. All
sensory systems, namely the visual, olfactory, mechanosensory,
thermosensory, and auditory systems, are capable of exhibiting
neuronal plasticity [1,2,3,4,5]. The ability to fine-tune sensory
responses is an essential survival tool for both vertebrates and
invertebrates.
The nematode C. elegans is inherently attracted to a variety of
volatile odors. Using a pair of head neurons, called the ‘AWC
Right’ and ‘AWC Left’, C. elegans can sense and seek out attractive
odors such as butanone, benzaldehyde, and isoamyl alcohol [6,7].
Chemosensation in AWC is mediated by the proposed direct
binding of odor to seven transmembrane G-protein coupled
receptors, which are exclusively localized to the sensory cilia [8,9].
Intracellularly, these receptors are coupled to heterotrimeric G-
proteins, whose a subunit can positively or negatively regulate
odortaxis [10]. There are at least four Ga subunits expressed in
AWC, these are: ODR-3; GPA-2; GPA-3; and GPA-13
[10,11,12]. Odor signaling in AWC is thought to utilize cGMP
as a secondary messenger because the receptor guanylyl cyclases
DAF-11 [13] and ODR-1 [14], as well as the cGMP gated calcium
channels TAX-2 [15] and TAX-4 [16] are all required for proper
AWC mediated odortaxis. Each factor has been shown to localize
to the AWC sensory cilia. Genetically encoded calcium reporters
have revealed that in the absence of odor the AWC exhibits high
intracellular calcium levels, and upon acute odor binding, the
intracellular calcium levels decrease leading to the hyperpolariza-
tion of the AWC neuron [17]. Thus, it is possible that odor
decreases cGMP levels which then favor closing of the cGMP-
gated channels and hyperpolarization of the AWC neuron. This
schema of acute odor binding in AWC shares many similarities
with the light response in photoreceptor cells where in the absence
of light calcium channels are open exhibiting a ‘dark current’.
Upon binding of photons of light, a cGMP phosphodiesterase is
activated which reduces cGMP levels causing closure of cyclic
nucleotide gated channels, and thus hyperpolarizing the cell
[18,19].
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After prolonged stimulation with a particular odor, C. elegans will
cease to seek out this odor. This decreased odor-attraction is
termed odor adaptation [2,20,21,22]. The Protein Kinase G
(PKG) EGL-4 has been shown to be necessary for adaptation of
the chemosensory response of the AWCs [20,23,24]. EGL-4 is
required in the AWC at the time of odor exposure for adaptation
to all AWC sensed odors [23]. EGL-4 contains a nuclear
localization sequence essential for long-lasting (.2 hour) stable
adaptation. Nuclear localization of EGL-4 has been shown to be
both necessary and sufficient to promote long-term adaptation
[25]. Furthermore, we previously demonstrated that the Ga
subunit protein ODR-3 [24] as well as the ability of EGL-4 to bind
cGMP [25] are both required for proper nuclear entry of EGL-4
after prolonged odor exposure. However, how these signals might
be integrated over time to regulate EGL-4 nuclear entry is not
known. Previously we published that genetic loss of the guanylyl
cyclase ODR-1 led to constitutively nuclear EGL-4 [24] while
here we show that decreases in cGMP levels at the time of odor
exposure (which we will refer to as ‘‘dynamic’’ changes in order to
contrast them with the chronically lower levels of cGMP that the
guanylyl cyclase deficient animals are predicted to experience
throughout their development) influence the localization of EGL-
4. We examined the localization of a GFP tagged EGL-4 molecule
in a strain that lacks the guanylyl cyclase DAF-11 [13]. This strain
is predicted to have lower levels of cGMP within AWC. We found
that in this mutant background GFP::EGL-4 was always in the
nucleus of AWC in naive (unexposed) animals. When we
examined the localization of GFP::EGL-4 in a cGMP phospho-
diesterase (PDE) mutant background [26], where cGMP levels are
predicted to be high, we found that EGL-4 failed to translocate to
the nucleus of AWC even after prolonged odor-exposure. Each
observation of animals that have been genetically modified to alter
cGMP levels is consistent with the explanation that odor may
induce nuclear translocation of EGL-4 by decreasing cGMP levels.
However, the possibility remained that the altered cGMP levels
that the animal experienced during development were responsible
for changing EGL-49s subcellular localization in the adult. To
distinguish between the possibilities that the lack of PDE activity
during development versus in the adult during prolonged odor
exposure block the nuclear entry of GFP::EGL-4, we asked if
dynamic (that is, during prolonged odor exposure) changes in
cGMP levels are able to alter the localization of EGL-4 in the
AWC. To test this, we treated animals with the PDE inhibitor 3-
isobutyl-1-methylxanthine (IBMX) at the time of odor exposure.
This treatment is predicted to increase cGMP levels. We found
that populations exposed to odor and IBMX for 80 minutes
displayed higher numbers of animals with cytosolic GFP::EGL-4
when compared to populations that had been exposed to odor
alone for 80 minutes. Thus, IBMX seemed to counteract odor
exposure. This led us to postulate that odor decreases cGMP levels
and that this decrease is required for nuclear translocation of
EGL-4. Consistent with this hypothesis, expression of the
phosphodiesterase PDE-3 [26] in odor naive adults increased the
number of animals that exhibited nuclear GFP::EGL-4. These
data suggest that decreases in cGMP levels may promote the
nuclear entry of EGL-4.
We had previously shown that morphologically intact AWC
cilia, as determined by fluorescent microscopic examination of the
endings of the AWC neurons, are required for cytoplasmic
localization of EGL-4 in an odor-naive animal [24]. In general, we
define wildtype or intact cilia morphology as a fan shaped sensory
ending of the AWC neuron and the absence of ectopic protrusions
at the end of the dendrite. To determine whether the morphology
or the function of the cilia is the key factor regulating EGL-4
localization as a function of prolonged odor exposure, we
examined mutants we found in a forward genetic screen that
display a constitutively nuclear EGL-4 phenotype. We found that
lesions in genes required for cilia biogenesis led to cilia
morphology defects, (the absence of a fan shape at the sensory
ending and the presence of ectopic protrusions) and constitutive
odor-independent accumulation of EGL-4 within the AWC
nucleus. Chemical chelation of calcium in the adult animals had
a similar effect. However, we show here using phosphodiesterase
mutants that elevating cGMP levels in cilia-disrupted animals was
sufficient to allow for appropriate cytoplasmic localization of EGL-
4. This suggests that proper cilia morphology is required for
maintaining basal cGMP levels, and that these cGMP levels even
in the context of cilia defects are sufficient to allow EGL-4 to reside
in the AWC cytoplasm.
cGMP signaling is an ancient and highly conserved feature of
ciliary signaling. It has been noted that many eukaryotes that have
lost cilia during evolution also lack cGMP signaling machinery
[27]. Furthermore, the PKG EGL-4 represents a highly conserved
molecular switch that shapes foraging behavior across multiple
organisms [28,29,30,31]. Thus, understanding the molecular
mechanisms that represent the intersection between cilia and
PKG activity has important implications in the sensory biology of
many eukaryotes. In this work we provide evidence that the
wildtype morphology of the sensory cilia may be required for a
level of cGMP that keeps EGL-4 in the cytoplasm of naive AWCs.
Likewise, the cilia morphology may also be required to produce
odor-induced fluctuations in cGMP levels that are needed to send
EGL-4 into the nucleus of the AWC.
Results
Changes in cGMP levels direct the nuclear entry of
GFP::EGL-4 in AWC
The AWC neurons enable C. elegans to sense various volatile
attractive odorants [6,7]. After prolonged exposure to one of these
odors, the protein kinase G EGL-4 will translocate from the
cytoplasm to the nucleus of the AWC [20,24,25]. This nuclear
entry of EGL-4 results in animals that are behaviorally adapted.
Since the AWC olfactory signal transduction pathway utilizes
cGMP as a second messenger [13,14,15,16], and EGL-49s ability
to bind cGMP is required for its ability to translocate into the
AWC nucleus [25], we decided to ask how changes in cGMP levels
affect EGL-4 nuclear localization.
Multiple guanylyl cyclases are expressed in the AWC [32] and
two have been shown to be required for AWC mediated
chemotaxis and to localize to the cilia of AWC: these are DAF-
11 and ODR-1 [13,14]. Previously, we showed that EGL-4 is
constitutively nuclear in an odr-1 mutant genetic background [25].
We examined the localization of GFP::EGL-4 in daf-11 and odr-1
mutants. Our laboratory has shown previously that the transgene
GFP::EGL-4 is a fully functional molecule that can rescue
adaptation defects in egl-4 null mutant animals [24,25]. We found
that GFP::EGL-4 is constitutively nuclear in these guanylyl cyclase
mutant animals (Figure 1A: naive wildtype = 10% nuclear, naive
odr-1(n1936)=100% nuclear (as seen in [24]), naive daf-
11(m47)=100%; p,0.0005 for wildtype naive animals versus
odr-1 and daf-11 naive mutant animals). One explanation of these
results is that reducing cGMP levels may promote the nuclear
entry of GFP::EGL-4.
To test this in another way we examined the localization of
GFP::EGL-4 in PDE mutants. There are four known cGMP PDEs
in C. elegans [26]: PDE-1; PDE-2; PDE-3; and PDE-5. In the
quadruple mutant pde-1 pde-5; pde-2; pde-3 we found that
Regulation of PKG Localization in the AWC Neurons
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GFP::EGL-4 is constitutively cytoplasmic. In wildtype animals
after prolonged benzaldehyde exposure 87% of animals display
nuclear GFP::EGL-4 and after prolonged butanone exposure 85%
of animals display nuclear GFP::EGL-4. In the PDE quadruple
mutant, however, after prolonged benzaldehyde exposure only
2.5% of animals display nuclear GFP::EGL-4 and after prolonged
butanone exposure only 1% of animals display nuclear
GFP::EGL-4 (Figure 1A: p=0.0006 for wildtype benzaldehyde
exposure versus PDE quadruple mutant benzaldehyde exposure,
p=0.0005 for wildtype butanone exposure versus PDE quadruple
mutant after prolonged butanone exposure). This further suggests
that decreases in cGMP levels may direct the nuclear entry of
GFP::EGL-4 and increases in cGMP may block the nuclear entry
of GFP::EGL-4.
Figure 1. Decreases in cGMP levels direct the nuclear entry of GFP::EGL-4 in AWC and promote adaptation. (A) Percent of animals
displaying nuclear GFP::EGL-4 in AWC of naive (black bars), benzaldehyde-exposed (gray bars) and butanone-exposed (white bars) treatments.
**Indicates p#0.005 significant differences between nuclear GFP::EGL-4 values of wildtype unadapted animals and odr-1 or daf-11 mutant unadapted
animals, and also significant differences between wildtype adapted and pde quadruple mutant adapted values. (B) Chemotaxis response of PDE
mutants and the guanylyl cyclase mutants daf-11 and odr-1 to the AWC sensed odor benzaldehyde. ‘‘2’’ indicates unexposed animals and ‘‘+’’
indicates exposed animals. **Indicates p#0.005 significant differences between chemotaxis index (CI) values between wildtype unexposed animals
and mutant unexposed animals. *Indicates p#0.05 significant differences between wildtype odor-exposed CI values and mutant odor-exposed CI
values. (C) Populations of GFP::EGL-4 (pyIs500) expressing animals were exposed to the odor benzaldehyde with or without the PDE inhibitor 3-
isobutyl-1-methylxanthine (IBMX). Populations exposed to 10 mM concentrations of IBMX displayed a reduced number of animals exhibiting nuclear
GFP::EGL-4 in AWC at 80 minutes post exposure to benzaldehyde and IBMX. *Indicates p#0.05 significant differences between odor treated animals
with IBMX versus odor treated animals without IBMX. (D) Expression of the cGMP phosphodiesterase PDE-3 under a heat-inducible promoter causes
some increase in the number of animals displaying nuclear GFP::EGL-4. *Indicates p#0.05 significant differences between wildtype and transgenic
animals after heat induction; **Indicates p#0.005 significant differences between transgenic animals with and without heat induction. ‘‘2’’ indicates
no heat induction and ‘‘+’’ indicates after heat induction. P values calculated using the Student’s t-test. Error bars represent the S.E.M.
doi:10.1371/journal.pone.0031614.g001
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Moreover, at the behavioral level, the PDE quadruple mutant is
defective in its ability to adapt to AWC sensed odors (Figure 1B
and Figure S1). We observed partial rescue of this behavioral
defect by replacing the pde genes in the PDE quadruple mutant
(Figure S2). To perform rescue we PCR amplified gDNA
amplicons containing ,1.5 kb upstream of the start site and
,1 kb downstream of the stop codon of the pde-1, pde-2, and pde-5
genes and using a fosmid containing part of the pde-3 locus we
made transgenic animals expressing these DNA fragments. As we
only observed partial rescue of the adaptation behavior defect with
these transgenic animals, we have not ruled the potential
contribution of other background mutations that may contribute
to the defect. Alternatively, there may be a precise balance
required between the pde gene products that may not have been
achieved in our attempted rescue perhaps due to incorrect levels or
insufficient cis-regulatory elements. Interestingly chemotaxis
behavior is intact in the PDE quadruple mutant. Wildtype
animals display a chemotaxis index (CI) of 0.19 after prolonged
benzaldehyde exposure. However, the PDE quadruple mutant
displayed a CI of 0.85 after prolonged benzaldehyde exposure
(p=0.013 for wildtype versus PDE quadruple mutant after
benzaldehyde exposure). Thus, chronically low cGMP (in guanylyl
cyclase mutants) or high cGMP (in phosphodiesterase mutants)
results in either constitutively nuclear or cytoplasmic EGL-4
respectively. Also, we did not observe adaptation defects in any of
the pde single mutants we examined (Figure 1B).
To investigate if dynamic (that is, at the time of odor exposure)
changes in cGMP levels are required to trigger the nuclear entry of
EGL-4, we blocked cGMP reduction acutely by treating EGL-
4::GFP expressing animals with the PDE inhibitor 3-isobutyl-1-
methylxanthine (IBMX: a non-selective inhibitor of both cAMP
and cGMP PDEs) during the period of prolonged odor exposure
that induces nuclear translocation of EGL-4 and adaptation. In
the negative control treatment, 92% of animals that were
incubated with the odor benzaldehyde for 80 minutes without
IBMX displayed nuclear GFP::EGL-4 (Figure 1C, blue line). This
number was reduced to 63% by adding 10 mM IBMX to the
odor. (Figure 1C: blue line versus red line, p=0.015 for odor
without IBMX versus odor with 10 mM IBMX). Incubating
animals with 1 mM or 5 mM IBMX and odor had no statistically
significant effect on the nuclear entry of GFP::EGL-4 (Figure 1C:
p=0.32 for 1 mM and p=0.14 for 5 mM), and incubating with
IBMX alone without odor had no effect on the localization of
GFP::EGL-4 (data not shown). We also increased the time frame
of IBMX exposure by pre-incubating animals in 10 mM IBMX
for 45 minutes prior to the co-incident exposure of 10 mM IBMX
with benzaldehyde for 80 minutes (Figure S3). However, we did
not observe a greater reduction in the nuclear entry of GFP::EGL-
4 by extending the IBMX treatment.
To investigate further if dynamic changes in cGMP levels
trigger the nuclear entry of GFP::EGL-4, we took the opposite
approach and asked whether acutely decreasing cGMP levels in
adults might be sufficient to send EGL-4 into the nucleus of a
naive animal. Thus, we overexpressed the cGMP phosphodies-
terase PDE-3 under a heat-inducible promoter (hsp16.2::pde-3.1a)
in odor-naive animals. Inducing the overexpression of pde-3 in
wildtype, odor naive adult animals resulted in modest but
significantly higher numbers of animals displaying nuclear
GFP::EGL-4 (Figure 1D). 32.5% of transgenic animals expressing
the hsp16.2::pde-3.1a transgene exhibit nuclear GFP::EGL-4 after
heat induction versus 19% of non-transgenic wildtype animals
(p=0.04). Taken together, these data argue that reducing or
increasing cGMP levels can dynamically modulate the nuclear
entry of GFP::EGL-4.
A forward genetic screen for constitutively nuclear
GFP::EGL-4 mutant animals
To identify determinants of the nuclear translocation of EGL-4
in AWC we conducted a forward genetic screen to isolate mutants
that display constitutively nuclear GFP::EGL-4. Two mutants
isolated from this screen are py825 and py827 (Figure 2A).
Interestingly, py825 and py827 are defective in their ability to
respond to AWC sensed odors (Figure 2B: wildtype benzaldehyde
chemotaxis index [CI] = 0.76, py825 benzaldehyde CI= 0.21
[p=0.008 compared to wildtype], py827 benzaldehyde
CI= 0.102 [p=0.01 compared to wildtype], wildtype isoamyl
alcohol CI = 0.8, py825 isoamyl alcohol CI = 0.18 [p=0.003
compared to wildtype], and py827 isoamyl alcohol CI = 0.06
[p=0.003 compared to wildtype]), and are also defective in
adaptation responses (Figure S4). They are also defective in their
ability to uptake the lipophillic dye DiD (Figure 2C). This dye will
fill sensory neurons that have ciliated endings exposed to the
external environment (Figure 2C, top panel ‘wildtype’), so this
indicated that the cilia have been disrupted. The mutant py825
was mapped to the right arm of LGX close to unc-3 (Figure 2D).
Complementation tests were performed with mutants in that
region and consequently we found that py825 was allelic to osm-1.
The AWC cilia defect and constitutively nuclear GFP::EGL-4
mutant phenotype could be rescued by introducing the array
(p)osm-1::OSM-1 into the genetic background of py825 (Figures 2J
and 2N). GFP::EGL-4 is nuclear in 100% of py825 animals. In
py825 transgenic animals expressing the rescuing array (p)osm-
1::OSM-1, the nuclear GFP::EGL-4 phenotype is reduced to 8%.
This is statistically indistinguishable from wildtype animals
(Figure 2N, p=0.46). OSM-1 is an ortholog of the intraflagellar
transport (IFT) complex B component, IFT172 [33,34]. In
sequencing the osm-1 locus, we found that the py825 lesion is
caused by a premature ochre stop codon in the tenth exon
(Figure 2D).
The mutant py827 was mapped near the center of LGI, close to
unc-13 (Figure 2E). Through complementation testing we then
found that py827 was allelic to che-3, and both the AWC cilia
defect and the constitutively nuclear GFP::EGL-4 mutant
phenotype could be rescued by introducing the array (p)che-
3::CHE-3 into the genetic background of py827 (Figures 2M and
2N). 100% of py827 mutant animals displayed nuclear GFP::EGL-
4. This was reduced to 6.33% in transgenic py827 animals
expressing the rescuing array (p)che-3::CHE-3. This is statistically
indistinguishable from wildtype animals (Figure 2N, p=0.408).
The gene che-3 encodes the isoform 1b of the dynein heavy chain
(DHC) [33,34,35]. Sequencing of the che-3 locus in py827 revealed
that the lesion is defined by a 397 bp deletion that removes the
final 54 bps of the final exon of the che-3 gene (Figure 2E and
Figure S5). Since the most prominent defects of mutants that
exhibit 100% nuclear EGL-4 in the naive animal are cilia defects,
this led us to propose that proper cilia morphology is important for
the cytosolic distribution of EGL-4 in the naive animal. This
corroborates our previous study [24] in which we noted that the
severity of a strain’s cilia defects correlated well with the percent of
the population that exhibits constitutively nuclear EGL-4.
The localization of GFP::EGL-4 does not alter AWC cilia
morphology
Neuronal plasticity is often accompanied by structural changes
[36,37,38]. This structural plasticity involves transcriptional
changes that are regulated by multiple kinases. These include:
Ca2+/calmodulin kinase CAMKII [39]; cyclin dependent kinase
CDK5 [40]; tyrosine receptor kinase TrKB [41]; and LIM-kinase
Regulation of PKG Localization in the AWC Neurons
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Figure 2. Forward genetic screen revealed that cilia defective mutants show constitutively nuclear EGL-4. (A) In wildtype naive animals
GFP::EGL-4 is diffuse throughout the entire cytosol of AWC, in the mutant py825, GFP::EGL-4 is constitutively accumulated in the nucleus of AWC and
GFP::EGL-4 is seen constitutively accumulated in the nucleus of AWC in the mutant py827. The constitutively nuclear GFP::EGL-4 mutants py825 and
py827 are chemotaxis and dye filling defective. (B) Chemotaxis responses of wildtype animals and the mutants, py825 and py827 to the AWC sensed
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(LIMK) [42], as well as many others. To test the hypothesis that
the localization of the PKG EGL-4 causes defects in the
morphology of the AWC cilia we asked whether changes in cilia
morphology occur as a result of the subcellular localization of
EGL-4. To examine this, we expressed a constitutively nuclear
form of EGL-4 in AWC. This transgene of EGL-4 contains a
second nuclear localization sequence (NLS) and is thus constitu-
tively nuclear [25]. In animals containing this transgene of EGL-4
the cilia of the AWC were normal (Figure 3B and Table S1). We
also examined whether overexpressing EGL-4 in the cytoplasm of
AWC could alter the morphology of the cilia in AWC. To this
end, we expressed a transgene of EGL-4 in which the NLS had
been deleted, causing EGL-4 to be constitutively cytoplasmic [25].
egl-4 mutant (n479 - null) animals expressing this transgene
exhibited normal cilia (Figure 3C and Table S1). Thus, the
localization of EGL-4 does not affect cilia morphology.
Though the above experiments did not identify a role for EGL-
4 localization in directing cilia morphology in the wildtype animal,
we next wanted to determine whether it might play a role in cilia
morphology that would be uncovered in the context of the IFT
complex B mutant background. Thus we asked whether we could
ameliorate the AWC cilia defect of osm-1(py825) mutant animals
by overexpressing the constitutively cytoplasmic GFP::EGL-4. In
this scenario we observed no rescue of the ciliopathy (Figure 3D
and Table S1). Taken together, these data suggest that the
morphology of the AWC cilia is not affected by the localization of
EGL-4 but rather EGL-49s localization is affected by the
morphology of the AWC cilia.
We wanted to understand whether the nuclear localization of
EGL-4 in mutants with defects in cilia morphology is dependent
upon its ability to bind cGMP. We examined a mutation (T276A)
within the low affinity binding site of EGL-4. Our decision to
examine a mutation affecting the low affinity cGMP binding site
was guided by previous studies into cGMP binding within PKGs.
These studies have shown that there are two cGMP bindings sites
(low affinity and high affinity) and they act allosterically to activate
the kinase domain with a Hill coefficient of 1.6 [43]. Initially,
cGMP saturates the high affinity site. When the high affinity
cGMP binding site is saturated the kinase becomes 50% active and
then the low affinity cGMP binding site is primed for cGMP
binding. When cGMP saturates the low affinity site the enzyme
becomes fully active. Thus, we inferred from biochemical studies
of PKGs that mutating either cGMP binding site would
dramatically decrease the ability of EGL-4 to perceive cGMP
changes. In fact, we previously demonstrated that mutation of key
residues within either cGMP binding site (low affinity or high
affinity) of EGL-4 resulted in a complete block in EGL-49s ability
to translocate to the nucleus after prolonged odor exposure [25].
Thus, we mutated the low affinity cGMP binding site within EGL-
4, and examined its localization in the che-3 mutant background.
Indeed, we found that mutating a key residue in one of the cGMP
binding sites (T276A) suppressed the constitutively nuclear
GFP::EGL-4 phenotype of che-3 mutant animals (Figure 3E). che-
3(e1124) mutant animals display nuclear GFP::EGL-4 in 100% of
cases. In che-3(e1124) transgenic animals expressing GFP::EGL-
4(T276A), in which the cGMP binding site is mutated, the nuclear
GFP::EGL-4 phenotype is reduced to 4%. This is statistically
indistinguishable from the percent of naive wildtype animals
displaying nuclear GFP::EGL-4 (p=0.84), and also indistinguish-
able from the number of naive wildtype transgenic animals
expressing the transgene GFP::EGL-4(T276A) (p=0.09). Impor-
tantly, the cilia defects of che-3(e1124) were not altered by
expression of this constitutively cytosolic form of EGL-4 (data not
shown). These data suggest that the native cGMP binding sites
within EGL-4 are required for nuclear entry of EGL-4, even in a
cilia biosynthesis mutant background such as che-3(e1124), which
normally exhibits a constitutively nuclear EGL-4 phenotype.
Mutation of one of the cGMP binding sites within EGL-4 may
disrupt proper cGMP occupancy that could normally direct
autophosphorylation or heterophosphorylation events important
for the nuclear entry of EGL-4. Alternatively, by interfering with
the ability of EGL-4 to bind cGMP, we may have altered the
conformation of EGL-4 in a way that inhibits its ability to
translocate to the nucleus.
High cGMP levels result in cytosolic EGL-4 even when
cilia morphology is defective
Our data so far describes a model whereby the AWC cilia
facilitate changes in cGMP levels, and these changes are
interpreted by EGL-4 to determine its proper localization. Next,
we tested if GFP::EGL-4 is cytosolic in the PDE quadruple mutant
background even when cilia morphology is perturbed. Calcium
has been shown to be critical in maintaining cilia morphology in C.
elegans [44], and we found that by soaking animals in high
concentrations of the calcium-chelating agent ethylene glycol
tetraacetic acid (EGTA), we could both induce perturbations of
cilia morphology in 22% of treated animals (Figure S6), and
increase the percent of animals with nuclear GFP::EGL-4
(Figure 4A). We define perturbation of cilia as an absence of the
cilia fan shape often accompanied by ectopic protrusions at the
distal tip. However, after soaking the PDE quadruple mutant
animals in high concentrations of EGTA we did not observe a
odors benzaldehyde (black bars) and isoamyl alcohol (gray bars). **Indicates p#0.005, and *indicates p#0.05 significant differences between mutants
and wildtype animals for each odor. (C) Dye filling with the lipophillic dye DiD in wildtype, py825, and py827 animals. The amphid neurons of the
mutants py825 and py827 fail to dye fill. (D) py825 encodes OSM-1, an ortholog of the intraflagellar transport (IFT) complex B component, IFT172.
Three factor mapping with dpy-6 unc-3 placed py825 close to unc-3. The molecular lesion of py825 is indicated by an arrowhead. (E) py827 encodes
CHE-3, the isoform 1b of the dynein heavy chain (DHC). Gene structure of che-3 and molecular lesion of py827. The molecular lesion of py827 is
indicated in the gene structure by a black horizontal line. Three factor mapping with dpy-5 unc-13 placed py825 near unc-13. Exon intron graphic
generated using the web application at: http://wormweb.org/exonintron. (F) Cartoon illustrating the features of the (p)odr-1::DsRed expression
pattern in the subsequent fluorescent confocal images. (G) Normal AWC cell and cilia morphology in wildtype animals. (H) AWC cilia defects displayed
by py825. (I) AWC cilia defects observed in py825/osm-1(pr816) trans heterozygotes. (J) Normal cilia morphology observed in py825 transgenic animals
expressing a rescuing array of OSM-1. (K) AWC cilia defect displayed by py827. (L) AWC cilia defects observed in py827/che-3(e1124) trans
heterozygotes. (M) Normal cilia morphology observed in py827 transgenic animals expressing a rescuing array of CHE-3. (N) Quantification of the
constitutively nuclear GFP::EGL-4 phenotype in py825 and py827 mutant animals. In a wildtype population very few animals display nuclear GFP::EGL-
4. The mutants py825 and py827 both display nuclear GFP::EGL-4 in all animals. The nuclear GFP::EGL-4 mutant phenotype of py825 is reduced to
wildtype levels in transgenic mutant animals expressing the rescuing array containing OSM-1, and similarly for py827 the nuclear GFP::EGL-4 mutant
phenotype is reduced to wildtype levels in transgenic mutant animals expressing the rescuing array containing CHE-3.**Indicates p#0.005 significant
differences between wildtype and mutant animals. P values calculated using the Students t-test. Error bars represent the S.E.M. For all images anterior
is to the left, and white dotted lines indicate outline of animal’s head region in (C) and white dotted rectangles indicate cilia structural defects in (H),
(I), (K) and (L).
doi:10.1371/journal.pone.0031614.g002
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Figure 3. Subcellular localization of GFP::EGL-4 in AWC does not affect cilia morphology. (A) Fluorescent confocal image of the AWC
neuron in a wildtype animal. Inset is a magnified view of the AWC cilia. (B) Fluorescent confocal image of wildtype animal expressing a constitutively
nuclear form of GFP::EGL-4. The animal displays normal AWC cilia. Inset is a magnified view of the AWC cilia. (C) An egl-4(n479) mutant animal
expressing constitutively cytosolic GFP::EGL-4 displays normal AWC cilia. Inset is a magnified view of the AWC cilia. (D) Though the py825 mutant
strain has constitutively nuclear EGL-4, expressing a cytosolic version of GFP::EGL-4 does not rescue the ciliopathy of py825 mutant animals. (E)
Quantification of the localization of GFP::EGL-4 in AWC. In a wildtype population very few animals display nuclear GFP::EGL-4. In the mutant che-
3(e1124), GFP::EGL-4 is in the nucleus of all animals. Mutating a key residue in the cGMP binding site of EGL-4 prevents the nuclear entry of GFP::EGL-4
in che-3(e1124) mutant animals.** indicates statistical significance at p,0.005 between wildtype and che-3 mutant animals For all images anterior is to
the left, and white dotted lines indicate outline of animal’s head region. P values calculated using the Student’s t-test. Error bars represent the S.E.M.
doi:10.1371/journal.pone.0031614.g003
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comparable increase in animals displaying nuclear GFP::EGL-4
(Figure 4A: wildtype animals after EGTA treatment = 28.3%,
PDE quadruple mutant animals after EGTA treatment = 3%,
p=0.01). They did, however, show evidence of cilia defects that
were comparable to the EGTA-treated wildtype animals (data not
shown). In fact, even without EGTA treatment a subset of PDE
quadruple mutants exhibit a decreased AWC cilia fan shape size,
and these animals still display cytosolic GFP::EGL-4. We also
compared the percentage of cilia defective animals exhibiting
nuclear GFP::EGL-4 after 100 mM EGTA treatment (Figure 4B)
between populations of wildtype animals and pde-1-5;2;3 quadru-
ple mutant animals. In the wildtype population, we observed that
100% of animals that had cilia defects also had nuclear
GFP::EGL-4, while in the pde-1-5;2;3 quadruple mutant popula-
tion, only 2.6% of cilia defective animals displayed nuclear
GFP::EGL-4 (Figure 4B: p,0.0005).
Next we used a genetic manipulation to examine the epistatic
relationship between elevated cGMP and cilia morphology in AWC
with respect to the localization of GFP::EGL-4. Previously it has
been shown that over-expression of a constitutively active form of the
small GTPase RAB-8 resulted in cilia defects in the AWB neurons in
C. elegans [44]. We expressed the constitutively active form of RAB-
8[Q67L] under an AWC exclusive promoter in wildtype animals
expressing GFP::EGL-4 and PDE quadruple mutants expressing
GFP::EGL-4. In most transgenic aimals expressing RAB-8[Q67L]
we did not observe the fan-shaped cilia of AWC and often observed
ectopic protrusions at the distal tip (Figure S7). Furthermore, in the
animals displaying perturbed cilia morphology we observed nuclear
GFP::EGL-4 in 74% of these animals versus 6% in the PDE
quadruple mutant background (Figure 4C: p=0.001 between
wildtype animals expressing RAB-8[Q67L] and PDE quadruple
mutants expressing RAB-8[Q67L]). Taken together, this suggests
Figure 4. cGMP levels are more important for regulating EGL-4 subcellular localization than is cilia morphology. (A) Populations of
naive wildtype animals that are soaked in high concentrations of the calcium chelating agent EGTA display significantly higher numbers of animals
with nuclear GFP::EGL-4, however, pde-1-5;-2;-3 mutant animals display significantly fewer numbers of nuclear GFP::EGL-4 animals after EGTA
treatment. *Indicates p#0.05 significant differences between wildtype EGTA treated animals and pde-1-5;-2;-3 mutant EGTA treated animals. (B) The
percentage of cilia defective animals displaying nuclear GFP::EGL-4 after 100 mM EGTA treatment was compared between wildtype and pde-1-5;2;3
mutant animals. For wildtype animals 100% of cilia defective animals exhibited nuclear GFP::EGL-4 and for pde-1-5;2;3 mutant animals 2.6% of cilia
defective animals displayed nuclear GFP::EGL-4. (C) Transgenic animals expressing the constitutively active form of RAB-8 in AWC displayed defects in
cilia morphology. We examined the localization of GFP::EGL-4 in wildtype and PDE quadruple transgenic animals expressing RAB-8[Q67L] that exhibit
defects in cilia morphology and compared to the percentage of nuclear localized GFP::EGL-4 in wildtype animals. 18% of wildtype animals display
nuclear GFP::EGL-4, 74% of cilia defective wildtype animals expressing RAB-8[Q67L] display nuclear GFP::EGL-4, and 6% of PDE quadruple mutants
expressing RAB-8[Q67L] in AWC display nuclear GFP::EGL-4. Between 30 and 60 cilia defective animals were counted for each trial and the means of
three separate trials conducted on separate days was graphed. **Indicates p#0.0005 significant differences between wildtype EGTA treated cilia
defective animals and pde-1-5;-2;-3 mutant EGTA treated cilia defective animals. *Indicates p#0.005 significant differences between wildtype animals
expressing RAB-8[Q67L] in AWC compared to pde-1-5;-2;-3 mutant animals expressing RAB-8[Q67L] in AWC. P values calculated using the Students t-
test. Error bars represent the S.E.M.
doi:10.1371/journal.pone.0031614.g004
Regulation of PKG Localization in the AWC Neurons
PLoS ONE | www.plosone.org 8 February 2012 | Volume 7 | Issue 2 | e31614
that elevated cGMP levels are epistatic to changes in cilia
morphology in relation to the localization of EGL-4.
Discussion
The elaborate structure of the AWC cilia is exquisitely formed for
function. The petal-shaped cilia provide a large membranous area
within which sensory and transduction proteins are localized. This
structure both concentrates and compartmentalizes sensory signal
transduction components. In concert with intracellular signaling
proteins, the factors within the AWC cilia provide a dynamic
response range as well as functional plasticity to the AWC neuron.
The protein kinase G EGL-4, which is found throughout the
AWC cytoplasm including the cilia, is a central regulator of
plasticity in the AWC neuron [20,23,25]. Sustained stimulation of
the AWC neuron triggers nuclear entry of EGL-4; this nuclear
entry is both necessary and sufficient to dampen sensory responses
of the AWC neuron [25]. The molecules and proteins that instruct
this dynamic event are not fully known. The aim of our current
study was to shed light on the proteins and molecules that
comprise the intersection between cilia and EGL-4 activity in the
AWC neuron. Using the localization of EGL-4 as a read-out, we
performed both a candidate screen and a forward genetic screen to
search for genes that are required for proper localization of EGL-4
in the AWC neuron. From these screens, we found that cGMP
levels whose dynamic changes likely require intact cilia morphol-
ogy are important for proper localization of EGL-4.
Non-motile cilia, like that of the AWC, are developed and
maintained by intraflagellar transport (IFT). IFT employs the
anterograde motor, Kinesin, to traffic ciliary cargo to the growing
end of the ciliary structure, and uses the retrograde motor,
cytoplasmic Dynein 1b, to traffic cargo back to the base of the
cilium [45,46,47]. These motors are associated with large multi-
protein assemblies called IFT complex A and IFT complex B.
Another assembly, the BBSome, stabilizes trafficking of the motors/
IFT particles A, B/cargo complex along the ciliary axoneme
[48,49,50]. Several proteins that comprise part of the sensory
machinery of AWC have been shown to localize to the cilia. These
include the guanylyl cyclases DAF-11 andODR-1 [13,14]. Guanylyl
cyclases catalyze the reaction of guanosine triphosphate (GTP) to
39,59-cyclic guanosine monophosphate (cGMP) and pyrophosphate.
The cGMP product serves as a second messenger capable of
activating numerous targets including protein kinases and ion
channels. To understand how cGMP changes determine the
localization of GFP::EGL-4, we examined the localization of EGL-
4 in mutants of DAF-11 and ODR-1. We found that, in these
mutants, a functional GFP tagged EGL-4 is constitutively localized
to the AWC nucleus. This is consistent with what we had previously
observed in the odr-1(null) mutants [24]. This suggested to us that
reducing cGMP levels in AWC might direct the nuclear entry of
GFP::EGL-4. If the levels of cGMP were indeed required to drop to
promote EGL-4 nuclear entry, we would expect that EGL-4 nuclear
entry would be blocked in animals in which cGMP levels cannot
decrease. To test this, we asked whether EGL-4 could enter the
nucleus in mutants that lacked cGMP phosphodiesterases. cGMP
phosphodiesterases break the phosphodiester bond within cGMP;
there are four predicted cGMP phosphodiesterases in the C. elegans
genome [26]. We examined the localization of GFP::EGL-4 in a
quadruple mutant of all four cGMP phosphodiesterases, and found
that GFP::EGL-4 was constitutively cytosolic in this mutant
background. This further suggested that decreasing cGMP levels
in the AWCmay promote the nuclear entry of EGL-4 and, inversely,
increasing cGMP levels in AWC blocks the nuclear entry of
GFP::EGL-4.
Interestingly, in our previous studies, over expression of the
guanylyl cyclase ODR-1 did not have the same effect as loss of
PDE expression [24]. In these previous studies, we found that over
expressing the guanylyl cyclase ODR-1 blocked adaptation, which
is similar to the loss of the PDEs. However, over expression of
ODR-1 did not block nuclear entry of EGL-4. Thus, the levels of
cGMP may not be raised sufficiently by over expression of ODR-1
to block nuclear entry but adaptation may require additional
events downstream of EGL-4 nuclear entry that over expression of
ODR-1 blocks. A better understanding of this discrepancy
between over expressing ODR- 1 and loss of the PDEs may be
facilitated by cGMP imaging studies.
We also demonstrated that dynamic changes in cGMP levels in
adults through over expression of the phosphodiesterase PDE-3
under a heat-inducible promoter or pharmacological treatment
with IBMX both modestly affected the nuclear entry of
GFP::EGL-4 in AWC. The discrepancy between the marked
extent of our ability to alter nuclear EGL-4 levels by genetic means
(genetic loss of PDEs), which resulted in a high percentage of
cytoplasmic EGL-4 animals in the presence of odor, versus the
modest block in nuclear translocation by acute inactivation of the
PDEs by IBMX might indicate either that the pharmacological
manipulations are less effective or that the PDEs are required for
additional developmental events that allow EGL-4 to enter the
AWC nucleus. Likewise, acute expression of a PDE from the heat-
inducible promoter was only able to promote nuclear translocation
in a small percent of the treated animals. This could indicate that
the treatment did not adequately reduce cGMP levels or that
additional factors, perhaps phosphorylation events downstream of
Ga activation, are required to promote nuclear entry of EGL-4.
Once again, cGMP-based imaging may help to distinguish
between these possibilities.
Interestingly, chemotaxis was not affected by loss of the PDEs in
contrast to adaptation, which was completely abolished. This
indicates that dynamic fluxes of cGMP via PDE may be less
important for acute odor recognition than adaptation. Although,
there may be alternate factors or pathways required to modulate
cGMP levels to allow for acute odor recognition. In a recent study
of the photoreceptor cell ASJ in C. elegans, Liu et al. [26]
demonstrated that phototransduction in ASJ is mediated by cGMP
signaling through guanylyl cyclases and CNG channels. Interest-
ingly, photocurrents were observed in pde-1 pde-5; pde-2; pde-3
quadruple mutants but exhibited very slow recovery, suggesting
that cGMP levels may be modulated independently of PDE
activity. Perhaps AWC exhibits a similar cascade, whereby acute
odor recognition is executed independent of PDE activity, and
more long-term events such as olfactory adaptation are defined by
PDE modulation of cGMP levels.
Though we have implicated fluctuations in cGMP as being
important for directing EGL-4 localization and initiating olfactory
adaptation, to develop a complete picture of how cGMP dynamics
shape AWC mediated behaviors, we will need to develop temporal
and spatial indicators of cGMP levels. Recently, several groups
have reported their data on a cGMP-sensitive GFP molecule
[51,52]. Developing this tool for use in C. elegans may provide
information on the temporal activity of cGMP in AWC, during
both acute odor recognition and sustained odor stimulation.
Materials and Methods
Strains and maintenance
Bristol N2, osm-1(py825), che-3(py827), dpy-6(e14) unc-3(e151),
dpy-5(e61) unc-13(e1091), osm-1(pr816), che-3(e1124), py825;
Ex[OSM-1], py827; Ex[CHE-3], egl-4(n479), N2; pyIs500[(p)odr-
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3::GFP::EGL-4; (p)odr-1::DsRed; (p)ofm-1::GFP], N2; Ex[(p)odr-
3::NLS::GFP::EGL-4], py825; Ex[(p)odr-3::GFP::DNLS EGL-4],
egl-4(n479); Ex[(p)odr-3::GFP::DNLS EGL-4], N2; Ex[(p)odr-
3::GFP::EGL-4 (T276A)], che-3(e1124); Ex[(p)odr-3::GFP::EGL-4
(T276A)], daf-11(m47), daf-11(m47); pyIs500, odr-1(n1936), odr-
1(n1936); pyIs500, pde-1(nj57) pde-5(nj49); pde-2(tm3098); pde-
3(nj59); Ex[(p)odr-3::GFP::EGL-4;(p)odr-1::DsRed; (p)ofm-1::GFP],
pde-1(nj57) pde-5(nj49); pde-2(tm3098); pde-3(nj59), pde-1(nj57) pde-
5(nj49); pde-2(tm3098); pde-3(nj59); Ex[(p)ceh-36::RAB8[Q67L],
N2; Ex[(p)ceh-36::RAB8[Q67L], unc-5(e53)IV; dpy-11(e224)V; lon-
2(e678)X, dpy-5(e61)I; bli-2(e768)II; unc-32(e189)III, pyIs500; Ex[-
elt-2::GFP, hsp16.2::pde-3.1a]. All strains were maintained on NGM
plates that were seeded with E. coli strain OP50 according to
standard protocol [53].
Constitutively nuclear GFP::EGL-4 screen
L4 hermaphrodite pyIs500 animals were mutagenized using
50 mM of EMS as described previously [53]. 4000 haploid
genomes were screened as an F2 microscope screen. Single F1
progeny were cloned onto individual OP50 seeded NGM plates
and F2 progeny were subsequently examined under 406
magnification for the constitutively nuclear GFP::EGL-4 pheno-
type. Mutant animals were rescued from microscope slides and
their progeny examined for transmission of the mutant phenotype.
Mapping of py825 and py827
The py825 mutant was assigned to LGX by the following cross:
py825 hermaphrodites were crossed with wildtype males and F1
male cross progeny were examined for the constitutively nuclear
GFP::EGL-4 phenotype - all male cross progeny were mutant for
the GFP::EGL-4 localization phenotype suggesting that py825 is
X-linked. Three factor mapping with unc-3 dpy-6 animals mapped
py825 very close to unc-3 (21/21 recombinant unc-3 non dpy-6
animals were wildtype for the GFP::EGL-4 phenotype and 9/9
dpy-6 non unc-3 recombinants displayed the constitutively nuclear
GFP::EGL-4 phenotype). Complementation tests were performed
with mutant animals harboring lesions in the chromosomal region
of unc-3 and from this we found that py825 and osm-1(pr816) are
allelic. The py827 mutant phenotype was assigned to LGI using
the mapping strains MT464 and MT465 (3/15 MT464 unc-5 IV
non dpy V non lon X recombinant animals were wildtype for the
GFP::EGL-4 phenotype, and 3/15 MT464 lon-2 non dpy non unc
recombinants were wildtype for the GFP::EGL-4 phenotype, and
1/14 MT465 dpy-5 I non bli II non unc III recombinants were
mutant for the GFP::EGL-4 phenotype). Three factor mapping
with unc-13 dpy-5 animals placed py827 very close to unc-13 (7/7
unc-13 non dpy-5 recombinants were wildtype for GFP::EGL-4
localization and 4/7 dpy-5 non unc-13 recombinant animals were
mutant for the GFP::EGL-4 phenotype). Complementation tests
with animals harboring mutations in this chromosomal region
were performed and it was found that py827 and che-3(e1124) are
allelic. AWC cilia surface area was measured for osm-1(py825) and
che-3(py827) (see Table S1 and Figure S8 for details). The osm-
1(py825) lesion is caused by a premature ochre stop codon in the
tenth exon changing a tyrosine (TAT) at amino acid position 496
to a STOP (TAA). The che-3(py827) lesion is defined by a 397 bp
deletion that removes the final 54 bps of the final exon of the che-3
gene and can be genotyped using the following primer pair: jz827-
F GACTCCTTCTCAACTACCAGCTAAACAATG and jz827-
R CATCTGCGAGACGTACTGATAGAATACAAG.
Dye filling assays
The lipophillic dye DiD (Invitrogen) was eluted in 2.5 ml of
dimethylformamide (DMF) to obtain a stock solution of 10 mg/
ml. Worms were washed from OP50 seeded plates two times in
M9 solution and exposed to DiD dye (1:1000) on a rotator for
2 hours. The worms were then washed two times in M9 and
allowed to recover on an OP50 seeded plate for 1 hour. The
animals were then washed off the plate two times in ddH20 and
examined using a TRITC filters under 406magnification.
Chemotaxis and adaptation assays
Chemotaxis was performed as described previously [7,20,23].
Briefly, four to five L4 animals were picked from plates grown at
25uC onto a 10 cm OP50 seeded plate and incubated at 25uC.
Animals were washed from these plates and chemotaxis and
adaptation assays were performed at room temperature. Odors
were diluted as follows unless otherwise stated: 1 ml benzaldehyde
(Sigma) in 200 ml EtOH, 1 ml butanone (Sigma) in 1000 ml EtOH,
and 1 ml isoamyl alcohol (Sigma) in 100 ml EtOH. Odor
adaptations were performed as described elsewhere [23,24].
Adaptation mixes were prepared by diluting odors as follows;
7.5 ml benzaldehyde into 100 ml S-Basal buffer, 11 ml butanone
into 100 ml S-Basal buffer and populations of animals were soaked
in the diluted odor for 80 minutes during long-term exposure. For
all assays between 100 and 200 animals were assayed in each assay
and each assay was repeated on separate days between three and
five times.
EGL-4 nuclear translocation assays
Four to five L4 animals were picked onto a 10 cm OP50 seeded
plate and incubated at 25uC. Animals were washed from these
plates and translocation assays were performed by exposing
mutant animals containing the GFP::EGL-4 transgene to odor
(adapted) or S-Basal (unadapted) for 80 minutes and then scoring
the number of worms exhibiting EGL-4 in the AWC ‘ON’ nucleus
after butanone exposure or in both AWC nuclei after benzalde-
hyde exposure under 406magnification. Wildtype pyIs500 worms
were included for every translocation assay as a positive control
using $75th percentile as the baseline for successful control assays
and treatment assay inclusion. Between twenty and fifty animals
were scored for each translocation assay and repeated on separate
days three to five times.
EGTA, IBMX treatment and heat shock protocol
For EGTA (Sigma) treatment, wildtype and pde-1 pde-5; pde-2;
pde-3 mutant animals containing the transgene GFP::EGL-4
(pyIs500) were incubated in 100 mM EGTA (pH 7.0) for
60 minutes and the subcellular localization of EGL-4 in AWC
was examined as described. For IBMX (Sigma) treatment,
GFP::EGL-4 (pyIs500) expressing animals were incubated with
adaptation solutions containing various IBMX concentrations
(1 mM, 5 mM, 10 mM). Between 50 and 80 animals were
counted for each assay, and the assay was repeated in three
separate trials. For the heat-induced expression of pde-3.1a, ,5 L4
pyIs500 (GFP::EGL-4) transgenic animals containing the
hsp16.2::pde-3.1a transgene were grown at 15uC for ,8 days, then
washed 3 times in S-basal buffer and placed on an unseeded plate
at 30uC for 2 hours. Then the subcellular localization of EGL-4 in
AWC was examined microscopically as described. Between 30 and
50 animals were examined on each day for both the control and
experimental populations and repeated in four separate trials on
different days.
Plasmid construction and transgenic strains
Construction of (p)odr-3::GFP::EGL-4, (p)odr-3::GFP::NLS::
EGL-4, (p)odr-3::GFP::EGL-4DNLS and (p)odr-3::GFP::EGL-
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4(T276A) was described previously [25]. The (p)ceh-
36::RAB8[Q67L] plasmid was generated by PCR amplifying the
RAB-8[Q67L] cDNA with primers flanked with EcoRI and KpnI
sites, the amplicon was digested with EcoRI and KpnI and inserted
into a (p)ceh-36 containing plasmid in pPD95.75. The OSM-1
rescuing array was a gift from Lesilee Rose, and the
WRM0637cB09 fosmid library clone was used for the CHE-3
rescuing array. The PCR fusion hsp16.2::pde-3.1a was made by
PCR amplifying the heat shock promoter hsp-16.2 and pde-3.1a
gene (from ATG start codon to ,1 kb downstream of stop codon)
from genomic DNA and fusing these products together by PCR
fusion as described previously [54]. The primer pair used to
amplify the heat shock promoter hsp16.2 was: hspF gatcaagag-
catttgaatcagaatatgg and hspR pde-3 fuse ttttgatttaaaaaccttggagtt-
catagtgagatgattatagtttgaagatttctaat. The primer pair used to
amplify the pde-3.1a product was: pde-3F atgaactccaaggtttttaaat-
caaaaaaaa and pde-3R gaaaaagggcagttttgttgtgtatgc. These prod-
ucts were fused using the nested primer pair: hspF nest
agttttttagatgcactagaacaaagcgtg and pde-3R nest gggcagttttgttgtg-
tatgcaaat. Rescuing pde transgenes were generated by PCR
amplifying gDNA fragments containing ,1.5 kb upstream of the
start site and ,1 kb downstream of the stop codon of the pde-1,
pde-2, and pde-5 genes. In the case of pde-3 we used the fosmid
WRM0623dE11 which contains part of the pde-3 locus. The PCR
amplicons and fosmid were co-injected together at 5 ng/ml each
and transgenic lines were assayed for rescue of the PDE quadruple
adaptation behavior defect. The following primer pairs were used
to amplify gDNA fragments from the pde-1, pde-2 and pde-5 loci:
pde-2F ttatcagctgattatttcgttttagtgatagtg and pde-2R caccatgatctc-
taattataatcccgc; pde-1F acaaaaatgtgttcaactgatacaattttc and pde-1R
acttgaactcggtgcggattccggaatc; pde-5F acgattcctacaaactacgaataccc-
tac and pde-5R gttctttgaaccaaaaggaaggcatac.
Supporting Information
Figure S1 Chemotaxis response of the PDE quadruple
mutant and the guanylyl cyclase mutants daf-11 and odr-
1 to the AWC sensed odor butanone. ‘‘2’’ indicates
unexposed animals and ‘‘+’’ indicates exposed animals. **Indicates
p#0.005 significant differences between chemotaxis index (CI)
values between wildtype unexposed animals and odr-1 or daf-11
mutant unexposed animals. *Indicates p#0.05 significant differ-
ences between wildtype odor-exposed CI values and pde quadruple
mutant odor-exposed CI values.
(TIF)
Figure S2 Chemotaxis response of wildtype, PDE
quadruple mutants, and PDE quadruple mutants ex-
pressing rescuing pde transgenes to the AWC sensed
odor benzaldehyde. ‘‘2’’ indicates unexposed animals and ‘‘+’’
indicates exposed animals. *Indicates p#0.05 significant differ-
ences between chemotaxis index values between PDE quadruple
mutants expressing rescuing pde transgenes plus and minus odor.
(TIF)
Figure S3 Populations of GFP::EGL-4 (pyIs500) express-
ing animals were incubated with 10 mM IBMX for
45 minutes and then exposed to the odor benzaldehyde
with 10 mM IBMX. The percentage of animals displaying
nuclear GFP::EGL-4 were compared to populations exposed to
odor alone for 80 minutes or populations exposed to no odor.
*Indicates p#0.05 significant differences.
(TIF)
Figure S4 Chemotaxis responses of wildtype animals
and the mutants, py825 and py827 to the AWC-sensed
odor benzaldehyde. ‘‘2’’ indicates unexposed animals and ‘‘+’’
indicates exposed animals. *indicates p#0.05 significant differenc-
es between mutants and wildtype animals.
(TIF)
Figure S5 PCR genotyping of the 397 bp deletion lesion
of py827. First lane: DNA marker; Lanes 2–4: py827 gDNA PCR
product; Lanes 5–7: N2 (wildtype) gDNA PCR product. For each
template (i.e. py827 and wildtype) the PCR reaction is performed in




Figure S6 Image of a wildtype animal after 60 mins
treatment with 100 mM EGTA. The white dotted box
indicates morphological defect in the fan-shaped AWC cilia after
treatment.
(TIF)
Figure S7 Image of the AWC neuron in a transgenic
animal expressing RAB-8[Q67L] under an AWC promot-
er. Expression of RAB-8[Q67L] in AWC causes defective cilia
morphology.
(TIF)
Figure S8 The AWC cilia surface area of adult animals
grown at room temperature was calculated using
VolocityH software. Using the ‘measure objects’ tool the region
of interest (ROI) was captured as indicated in image by a blue box
and measured (mm2).
(TIF)
Table S1 The AWC cilia surface area of adult animals
grown at room temperature was calculated using
VolocityH software. The most distal (anterior) 5 mm region
was selected as the region of interest (ROI) and this area was
measured (mm2) using the ‘measure objects’ tool in VolocityH.
Refer to Figure S8 for image on ROI capture. S.D. = standard
deviation. *Indicates p#0.05 significant differences compared with
wildtype animals using a two-tailed Student t-test.
(DOC)
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